Details for 2017777211

Up to date per 02.04.2026

Actions

Title / Product Name

VERWENDUNG VON C-MET-HEMMERN ZUR BEHANDLUNG VON KREBS MIT MET-MUTATIONEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017777211

EP Publication Number

3515418

E-Number

1381674

Language

PCT Number

EP17073894

Publication Date

31.07.2019 A

14.04.2021 B1

Registration Date

14.04.2021

AT Publication Date

15.05.2021

Application Date

21.09.2017

Registration Number

Priorities

22.09.2016

201616116

IPC

A61K 31/4985 20060101AFI20200623BHEP

Maximum Duration of Protection

21.09.2037

Owner

Astrazeneca AB 151 85 SödertäljeSE

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

FRIGAULT, Melanie MaeAstraZeneca 35 Gatehouse Drive Waltham, MA 02451US

Information about Fees